Free Trial
NASDAQ:MEIP

MEI Pharma (MEIP) Stock Price, News & Analysis

MEI Pharma logo
$2.69 -0.06 (-2.18%)
Closing price 07/10/2025 03:59 PM Eastern
Extended Trading
$2.70 +0.01 (+0.37%)
As of 07/10/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About MEI Pharma Stock (NASDAQ:MEIP)

Key Stats

Today's Range
$2.65
$2.80
50-Day Range
$2.04
$2.84
52-Week Range
$1.46
$4.10
Volume
8,218 shs
Average Volume
44,307 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

MEI Pharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
38th Percentile Overall Score

MEIP MarketRank™: 

MEI Pharma scored higher than 38% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for MEI Pharma are expected to grow in the coming year, from ($5.10) to ($3.71) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MEI Pharma is -0.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MEI Pharma is -0.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    MEI Pharma has a P/B Ratio of 0.54. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about MEI Pharma's valuation and earnings.
  • Percentage of Shares Shorted

    0.02% of the float of MEI Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    MEI Pharma has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MEI Pharma has recently decreased by 51.85%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    MEI Pharma does not currently pay a dividend.

  • Dividend Growth

    MEI Pharma does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.02% of the float of MEI Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    MEI Pharma has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MEI Pharma has recently decreased by 51.85%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for MEI Pharma this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, MEI Pharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.12% of the stock of MEI Pharma is held by insiders.

  • Percentage Held by Institutions

    52.38% of the stock of MEI Pharma is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about MEI Pharma's insider trading history.
Receive MEIP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MEI Pharma and its competitors with MarketBeat's FREE daily newsletter.

MEIP Stock News Headlines

Your blueprint for crypto wealth
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
MEI Pharma Registered Shs
MEI Pharma (NASDAQ:MEIP) Stock, Option Chain
See More Headlines

MEIP Stock Analysis - Frequently Asked Questions

MEI Pharma's stock was trading at $2.46 on January 1st, 2025. Since then, MEIP stock has increased by 9.3% and is now trading at $2.69.

MEI Pharma, Inc. (NASDAQ:MEIP) announced its quarterly earnings results on Tuesday, May, 13th. The company reported ($0.39) earnings per share for the quarter.

MEI Pharma's stock reverse split on the morning of Monday, April 17th 2023.The 1-20 reverse split was announced on Monday, April 17th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, April 17th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of MEIP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MEI Pharma investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Adobe (ADBE), CymaBay Therapeutics (CBAY) and Jabil (JBL).

Company Calendar

Last Earnings
5/13/2025
Today
7/11/2025
Next Earnings (Estimated)
9/17/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MEIP
Previous Symbol
NASDAQ:MSHL
CIK
1262104
Employees
100
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($4.75)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$17.78 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-77.00%
Return on Assets
-64.79%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
16.78
Quick Ratio
16.78

Sales & Book Value

Annual Sales
$65.30 million
Price / Sales
N/A
Cash Flow
$5.85 per share
Price / Cash Flow
0.46
Book Value
$4.96 per share
Price / Book
0.54

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Optionable
Beta
0.19

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:MEIP) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners